GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Global Corp (ASX:AVR) » Definitions » Price-to-Free-Cash-Flow

Anteris Technologies Global (ASX:AVR) Price-to-Free-Cash-Flow : N/A (As of May. 08, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Global Price-to-Free-Cash-Flow?

As of today (2025-05-08), Anteris Technologies Global's share price is A$6.71. Anteris Technologies Global's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-4.85. Hence, Anteris Technologies Global's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Anteris Technologies Global's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:AVR's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.77
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Anteris Technologies Global's Free Cash Flow per Share for the six months ended in Dec. 2024 was A$-2.40. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-4.85.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -22.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -6.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 12.70% per year.

During the past 13 years, Anteris Technologies Global's highest 3-Year average Free Cash Flow per Share Growth Rate was 30.60% per year. The lowest was -43.80% per year. And the median was 9.85% per year.


Anteris Technologies Global Price-to-Free-Cash-Flow Historical Data

The historical data trend for Anteris Technologies Global's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Global Price-to-Free-Cash-Flow Chart

Anteris Technologies Global Annual Data
Trend Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Anteris Technologies Global Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Anteris Technologies Global's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Anteris Technologies Global's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies Global's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Price-to-Free-Cash-Flow falls into.


;
;

Anteris Technologies Global Price-to-Free-Cash-Flow Calculation

Anteris Technologies Global's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=6.71/-4.849
=N/A

Anteris Technologies Global's Share Price of today is A$6.71.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies Global's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was A$-4.85.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Anteris Technologies Global  (ASX:AVR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Anteris Technologies Global Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Anteris Technologies Global's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies Global Business Description

Traded in Other Exchanges
N/A
Address
9 Sherwood Road, Level 3, Suite 302, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.